Virtual Hub New On-Demand

Oct
01

Weighing the Evidence: A Pharmacy Approach to Stroke Prevention in Obese Patients with Non-Valvular Atrial Fibrillation

In this CME Outfitters On Demand webcast, expert faculty review key aspects of the prescribing information, guidelines, and recently published safety and efficacy data for DOACs and warfarin in order to enable pharmacists and other clinicians to support evidence-based therapeutic treatment decisions in obese patients with NVAF.

Read More
By Ben Stoner |
DETAIL
Sep
30

The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer: Guidance for Today and the Path Forward

    In this CME Outfitters OnDemand webcast, integrations of animated 3-D models will provide visual representation of the mechanisms and characteristics of antibody drug conjugates (ADCs) in NSCLC to complement expert faculty insights and evidence supporting testing strategies to identify predictive biomarkers, emerging treatment options for advanced or metastatic NSCLC, and best practices for […]

Read More
DETAIL
Jul
09

Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis

Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal disease with a significant impact on quality of life and functional ability. Despite the data showing the overall impact of PsA, delays in diagnosis are common, which can lead to long-term joint damage and functional disability. In this CME Outfitters OnDemand activity, expert faculty focus on assessment, […]

Read More
DETAIL
Jun
28

Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS

In this On Demand webcast, Drs. Fred Lublin, Joseph Berger, and Anne Cross share expert insights on improving outcomes in relapse remitting multiple sclerosis.

Read More
DETAIL
Jun
27

Keeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation

  Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. This CME Outfitters OnDemand webcast will feature expert […]

Read More
DETAIL
Jun
24

Targeted Therapy for HER2 and HER3-Positive Breast Cancer: Navigating the Evolving Treatment Landscape

Breast cancer (BC) is a heterogeneous disease with human epidermal growth factor receptor 2 (HER2) overexpression and/or amplification observed in 20%-30% of cases. HER2-positive (+) BC correlates with poor clinical outcomes unless appropriately treated with targeted therapy. Despite significant therapeutic advances, many patients experience disease progression with resistance to targeted agents developing over the course […]

Read More
DETAIL
Jun
23

Giving Shingles Immunization Your Best Shot: Implementing a Shingles Vaccination Protocol in Your Practice

Shingles, or herpes zoster, is a common secondary infection for older patients. Almost all individuals over the age of 50 are latently infected with varicella zoster virus (VZV) and therefore are at risk of developing shingles with reactivation of latent VZV. This CME Outfitters OnDemand webcast will focus on the burden imposed by shingles, improving […]

Read More
DETAIL
Jun
22

Beyond the Old Paradigms: Novel Approaches to the Treatment of Chronic Idiopathic Constipation

Chronic idiopathic constipation (CIC) affects 35 million adults in the United States, making it one of the most common gastrointestinal disorders. Despite the high prevalence, CIC is often underdiagnosed and undertreated, which exacts a functional, psychosocial, and economic toll on patients and their loved ones. The current treatment goal in CIC is multi-symptom relief, but […]

Read More
DETAIL